ADVANCED BILIARY TRACT CARCINOMA
Clinical trials for ADVANCED BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on biliary cancers: targeted drug plus chemo shows promise
Disease control OngoingThis study tests whether adding the targeted drug binimetinib to standard chemotherapy (mFOLFOX6) can shrink tumors or extend survival in people with advanced biliary tract cancers that have certain genetic changes (MAPK pathway alterations). About 66 participants whose cancer wo…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New cocktail of drugs shows promise against tough bile duct cancer
Disease control OngoingThis phase 2 trial tests a combination of immunotherapy (camrelizumab), a targeted therapy (apatinib), and chemotherapy (gemcitabine and oxaliplatin) given before and after surgery for 30 people with advanced biliary tract cancer. The goal is to see if this approach can shrink tu…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC